Endothelial and adrenergic dysfunction in Raynaud's phenomenon and scleroderma

Journal of Rheumatology

Volumn 26, Issue 11, 1999, Pages 2386-2388

  Freedman, Robert R ^a,b   Girgis, Reda ^a   Mayes, Maureen D ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Blood vessels; Endothelium; Raynaud's phenomenon; Scleroderma

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CLONIDINE; DILTIAZEM; LISINOPRIL; METHACHOLINE; NABUMETONE; NIFEDIPINE; NITROPRUSSIDE SODIUM; OMEPRAZOLE; PENICILLAMINE; PENTOXIFYLLINE; PREDNISONE; VASODILATOR AGENT;

ADRENERGIC SYSTEM; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; MALE; PLETHYSMOGRAPHY; PRIORITY JOURNAL; RAYNAUD PHENOMENON; SCLERODERMA; SKIN BLOOD FLOW; VASCULAR ENDOTHELIUM; VASOSPASM;

ADRENERGIC AGONISTS; CLONIDINE; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; MALE; METHACHOLINE CHLORIDE; MIDDLE AGED; RAYNAUD DISEASE; RECEPTORS, ADRENERGIC; SCLERODERMA, SYSTEMIC; VASODILATION; VASODILATOR AGENTS;

EID: 0032730980     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Freedman RR, Sabhawal SC, Desai N, Wenig P, Mayes M. Increased alpha-adrenergic responsiveness in idiopathic Raynaud's disease. Arthritis Rheum 1989;32:61-5.
2. Freedman RR, Molen M, Migaly P, Mayes M. Cold-induced potentiation of alpha-2-adrenergic vasoconstriction in primary Raynaud's disease. Arthritis Rheum 1993;36:685-90.
3. Freedman RR, Baer RP, Mayes MD. Blockade of vasospastic attacks by alpha-2-adrenergic but not alpha-1-adrenergic antagonists in idiopathic Raynaud's disease. Circulation 1995;92:1448-51.
4. Khan F, Litchfield SJ, McLaren M, Veale DJ, Littleford RC, Belch JJF. Oral L-arginine supplementation and cutaneous vascular responses in patients with primary Raynaud's phenomenon. Arthritis Rheum 1997;40:352-7.
5. Ringqvist A, Jonason T, Leppert J, Ringqvist I. Non-invasive investigation of endothelium-dependent dilatation of the brachial artery in women with primary Raynaud's phenomenon, Clin Sci 1998;94:239-43.
6. Rodnan GP, Myerowitz RL, Justh GO. Morphologic changes in digital arteries of patients with progressive systemic sclerosis (scleroderma) and Raynaud phenomenon. Medicine 1980;59:393-408.
7. Norton WL, Nardo JM. Vascular disease in progressive systemic sclerosis (scleroderma). Ann Intern Med 1970;73:317-24.
8. Vajda K, Kadar A, Kali A, Urai L. Ultrastructural investigations of finger pulp biopsies: A study of 31 patients with Raynaud's syndrome. Ultrastruc Pathol 1982;3:175-86.
9. Lewis T. Experiments relating to the peripheral mechanism involved in spasmodic arrest of circulation in fingers, a variety of Raynaud's disease. Heart 1929;15:7-10.
10. Freedman RR, Mayes MD, Sabharwal SC. Induction of vasospastic attacks despite digital nerve block in Raynaud's disease and phenomenon. Circulation 1989;80:859-62.
11. American Rheumatism Association. Preliminary criteria for the classification of systemic sclerosis (scleroderma). N Engl J Med 1990;323:1486-7.
12. Duff RS. Adrenaline sensitivity of peripheral blood vessels in human hypertension. Br Heart J 1957;19:45-55.
13. Winer BJ, Brown DR, Michels KM. Statistical principles in experimental design. New York: McGraw-Hill; 1991.
14. Coffman JD, Cohen RA. Intra-arterial vasodilator agents to reverse human finger vasoconstriction. Clin Pharmacol Ther 1987;41:574-9.
15. Creager MA. Gallagher SJ, Girerd XJ, Coleman SM, Dzau VJ, Cooke JP. L-arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans. J Clin Invest 1992;90:1248-53.
16. Folkow B, Grimby G, Thulesius O. Adaptive structural changes of the vascular walls in hypertension and their relation to the control of the peripheral resistance. Acta Physiol Scand 1958;44:255-72.
17. Fujimoto S, Itoh T. Role of nitric oxide and nitric oxide-independent relaxing factor in contraction and relaxation of rabbit blood vessels. Eur J Pharmacol 1997;330:177-84.
18. Sunano S, Li-Bo Z, Matsuda K, Sekigucki F, Shimamura K. Endothelium-dependent relaxation by alpha 2-adrenoceptor agonists in spontaneously hypertensive rat aorta. J Cardiovasc Pharmacol 1996;27:733-9.
19. Bockman CS, Gonzalez-Cabrera I, Abel PW. Alpha-2 adrenoceptor subtype causing nitric oxide-mediated vascular relaxation in rats. J Pharmacol Exp Ther 1996;278:1235-43.
20. Khan F, Coffman JD. Enhanced cholinergic cutaneous vasodilation in Raynaud's phenomenon. Circulation 1994;89:1183-8.
21. 2 receptor hypersensitivity in Raynaud's phenomenon. J Vasc Med Biol 1990;2:100-6.